Research output: Contribution to conference › Paper › peer-review
The use of vibro-acoustic stimuli for blood pressure lowering in the hypertensive patients. / Ponomarenko, G. N.; Fedorov, V. A.; Obrezan, A. G.; Kulikov, A. N.; Stupnitckiy, A. A.; Tishakov, A. Yu.
2003. 3839-3842 Paper presented at Proceedings of the Tenth International Congress on Sound and Vibration, Stockholm, Sweden.Research output: Contribution to conference › Paper › peer-review
}
TY - CONF
T1 - The use of vibro-acoustic stimuli for blood pressure lowering in the hypertensive patients
AU - Ponomarenko, G. N.
AU - Fedorov, V. A.
AU - Obrezan, A. G.
AU - Kulikov, A. N.
AU - Stupnitckiy, A. A.
AU - Tishakov, A. Yu
PY - 2003
Y1 - 2003
N2 - The research was undertaken with the purpose to find out the opportunities of the blood pressure (BP) control in the hypertensive patients with using of vibro-acoustic devise VITAFON. Investigated group included 30 patients, performed the vibro-acoustic VITAFON therapy according to the special treatment scheme. The BP of the pts with mild AH were lowered up to approximately 6 mm Hg for systolic and 5 mm Hg for the diastolic, comparing to initial levels (p>0.05). For the patients with moderate AH the effect was more essential. Systolic BP was diminished up to 7+2 mm Hg and diastolic BP - up to 8+3 mm Hg (p<0.05). Presented data show an independent and additive antihypertensive effects of the vibro-acoustic therapy with VITAFON.
AB - The research was undertaken with the purpose to find out the opportunities of the blood pressure (BP) control in the hypertensive patients with using of vibro-acoustic devise VITAFON. Investigated group included 30 patients, performed the vibro-acoustic VITAFON therapy according to the special treatment scheme. The BP of the pts with mild AH were lowered up to approximately 6 mm Hg for systolic and 5 mm Hg for the diastolic, comparing to initial levels (p>0.05). For the patients with moderate AH the effect was more essential. Systolic BP was diminished up to 7+2 mm Hg and diastolic BP - up to 8+3 mm Hg (p<0.05). Presented data show an independent and additive antihypertensive effects of the vibro-acoustic therapy with VITAFON.
UR - http://www.scopus.com/inward/record.url?scp=2342429859&partnerID=8YFLogxK
M3 - Paper
AN - SCOPUS:2342429859
SP - 3839
EP - 3842
T2 - Proceedings of the Tenth International Congress on Sound and Vibration
Y2 - 7 July 2003 through 10 July 2003
ER -
ID: 89272661